Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.

Market Analysis and Insights: Global Tianeptine Market
In 2020, the global Tianeptine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Tianeptine Scope and Market Size
The global Tianeptine market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Tianeptine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Patent
Generic

Segment by Application
Depression and Anxiety
Irritable Bowel Syndrome

By Company
Servier
Lupin Limited
PharmaS
Antibiotice
Serdia Pharmaceuticals
Alvogen
Bausch Health
Genefar B.V.
Arena Pharmaceuticals
Glenmark
Novartis
Dongwha Pharm
Liconsa SA
Mylan
Adamed
Neuraxpharm Arzneimittel
Grupo Insud

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE